1
|
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients. Eur J Dermatol 2023; 33:680-685. [PMID: 38465550 DOI: 10.1684/ejd.2023.4584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/12/2024]
Abstract
Sarcoidosis is a systemic disease that affects the skin in about 25% of patients. The treatment of cutaneous sarcoidosis is guided by the extent of lesions, associated symptoms and organ involvement. To evaluate rates of response to various potential first-line treatments for cutaneous sarcoidosis during the year following treatment initiation. This retrospective multicentre study included 120 patients with cutaneous sarcoidosis. Treatment response was assessed retrospectively from the patients' medical records. Univariate logistic regression analysis, with an estimation of unadjusted odds ratios (OR) and their 95% CI ,was performed to identify factors associated with complete cutaneous remission (CR), followed by multivariate logistic regression analysis. At one year, 43 of the 120 (36%) included patients had CR. The best response rates were obtained with oral corticosteroids (12/21, 57%), followed by a combination of hydroxychloroquine and topical steroids (6/13, 46%). In multivariate analysis, lupus pernio was the only predictor of a poor cutaneous response. We suggest the use of a combination of hydroxychloroquine and topical steroids as an optimal first-line treatment for cutaneous sarcoidosis, given the known adverse effects of systemic corticosteroids.
Collapse
Affiliation(s)
- Elisabeth Cohen
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Coralie Lheure
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Saskia Ingen-Housz-Oro
- Department of Dermatology, APHP, Mondor Hospital, Paris, France, EpiDermE, University Paris Est Créteil, Créteil, France
| | - Claire Hotz
- Department of Dermatology, APHP, Mondor Hospital, Paris, France
| | - Thomas Bettuzzi
- Department of Dermatology, APHP, Mondor Hospital, Paris, France
| | | | | | - Lydia Deschamps
- Department of Pathology, APHP, Bichat Hospital, Paris, France
| | - Matthieu Mahevas
- Department of Internal Medicine, APHP, Mondor Hospital, Paris, France
| | - Benjamin Terrier
- Department of Internal Medicine, APHP, Cochin Hospital, Paris, France
| | - Pierre Sohier
- Department of Pathology, APHP, Cochin Hospital, Paris, France
| | - Sarah Guegan
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Nora Kramkimel
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | | | - Johan Chanal
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Benedicte Oulès
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Selim Aractingi
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Vannina Seta
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Nicolas Dupin
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| |
Collapse
|
2
|
Fottorino A, Richard MA, Prouteau C, Balland C, Villani AP, Buche S, Hotz C, Delage M, Nassif A, Cogrel O, Jouan N. Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices. Ann Dermatol Venereol 2023; 150:227-229. [PMID: 36894389 DOI: 10.1016/j.annder.2022.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 05/23/2022] [Accepted: 09/14/2022] [Indexed: 03/09/2023]
Affiliation(s)
- A Fottorino
- CEReSS-EA 3279, Research Centre in Health Services and Quality of Life, Aix Marseille University, Dermatology Department, University Hospital Timone, Assistance Publique-Hôpitaux de Marseille, APHM, 13385 Marseille, France.
| | - M-A Richard
- CEReSS-EA 3279, Research Centre in Health Services and Quality of Life, Aix Marseille University, Dermatology Department, University Hospital Timone, Assistance Publique-Hôpitaux de Marseille, APHM, 13385 Marseille, France
| | - C Prouteau
- Department of Dermatology, University Hospital of Angers, Angers, France
| | - C Balland
- Department of Dermatology, CHU Rennes, Rennes, France
| | - A-P Villani
- Hospices Civils de Lyon, Service de Dermatologie, Hôpital Edouard Herriot, Lyon, France
| | - S Buche
- Department of Dermatology, Hurriez Hospital, Lille, France
| | - C Hotz
- Department of Dermatology, Hôpital Henri Mondor, Créteil, France
| | - M Delage
- Medical Centre, Pasteur Institute, Paris, France
| | - A Nassif
- Medical Centre, Pasteur Institute, Paris, France
| | - O Cogrel
- Department of Dermatology, Saint André Hospital, Bordeaux, France
| | - N Jouan
- Dermatology Practice, Brest, France
| |
Collapse
|
3
|
Weiss M, Assier H, Hotz C, Hua C, Thomas L, Wolkenstein P, Ingen-Housz-Oro S. Acute generalized exanthematous pustulosis: Clinico-biological profile and inducing drugs in 83 patients. J Eur Acad Dermatol Venereol 2023; 37:e776-e778. [PMID: 36734481 DOI: 10.1111/jdv.18940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Accepted: 02/01/2023] [Indexed: 02/04/2023]
Affiliation(s)
- M Weiss
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France
| | - H Assier
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - C Hotz
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - C Hua
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France.,Univ Paris est Créteil EpidermE, Créteil, France
| | - L Thomas
- Department of Pharmacovigilance, AP-HP, Henri-Mondor Hospital, Creteil University, Créteil, France
| | - P Wolkenstein
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - S Ingen-Housz-Oro
- Department of Dermatology, AP-HP, Henri-Mondor Hospital, Creteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France.,Univ Paris est Créteil EpidermE, Créteil, France
| |
Collapse
|
4
|
Alzahrani M, Coste V, Konstantinou MP, Reguiai Z, Villani A, Hotz C, Viguier M, Pruvost-Balland C, Dupuy A, Wolkenstein P, Brun A, Aubin F, Gallais Sérézal I. Treatment of dissecting cellulitis of the scalp with tumor necrosis factor inhibitors: a retrospective multicenter study. Clin Exp Dermatol 2023; 48:528-530. [PMID: 36702808 DOI: 10.1093/ced/llad036] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 01/23/2023] [Accepted: 01/24/2023] [Indexed: 01/28/2023]
Abstract
Although retinoids are considered as the most effective treatment, management of dissecting cellulitis of the scalp (DCS) is often challenging. A multicenter retrospective study was conducted to evaluate the efficacy of anti-TNF agents in treating DCS after failure of other conventional treatments. Twenty-six patients were included. After a mean treatment duration of 19 ± 21 months, the mean PGA score decreased by 56% as the number of abscesses (-89%), the number of inflammatory nodules (-70%), the mean NRS score for pain severity (-68%) and the mean DLQI (-29%). This study confirms the efficacy of anti-TNF agents in treating DCS patients resistant to conventional therapies.
Collapse
Affiliation(s)
| | - Victor Coste
- Sce de Dermatologie, CHU et Inserm1098, Besançon, France
| | | | - Ziad Reguiai
- Sce de Dermatologie, Clinique Courlancy, Reims, France
| | - Axel Villani
- Sce de Dermatologie, Hospices Civils de Lyon, France
| | - Claire Hotz
- Centre Hospitalier Jacques Puel, Rodez, France.,Sce de Dermatologie, Hôpital Henri Mondor, APHP, UPEC, Créteil, France
| | - Manuelle Viguier
- Sce de Dermatologie, Hôpital Robert-Debré, Université Reims-Champagne Ardenne, Reims, France
| | | | | | | | - Aurore Brun
- Sce de Dermatologie, CHU de Toulouse, France
| | - François Aubin
- Sce de Dermatologie, CHU et Inserm1098, Besançon, France
| | | | | |
Collapse
|
5
|
Grolleau C, Calugareanu A, Demouche S, Nosbaum A, Staumont-Sallé D, Aubert H, Cassius C, Jachiet M, Saussine A, Bagot M, Bachelez H, Battistella M, Hotz C, Du Thanh A, Crépy MN, Bergerat D, Merandet M, Onifarasoaniaina R, Alberdi A, How-Kit A, Bouaziz JD, Le-Buanec H. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis. J Invest Dermatol 2023; 143:711-721.e7. [PMID: 36610660 DOI: 10.1016/j.jid.2022.10.015] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Revised: 10/14/2022] [Accepted: 10/18/2022] [Indexed: 01/07/2023]
Abstract
Dupilumab is a therapeutic antibody targeting IL-4 and IL-13 receptor subunit alpha used for the treatment of patients with atopic dermatitis (AD). Cases of psoriasis-like reactions induced under dupilumab treatment (dupilumab-induced psoriatic eruption [DI-Pso]) for AD were recently reported. To understand the pathogenesis of DI-Pso, we performed gene expression profiling studies on skin biopsies of DI-Pso (n = 7) compared with those of plaque psoriasis, AD, and healthy controls (n = 4 each). Differential gene expression was performed using enrichment and Gene Ontology analysis. Gene expression was validated by qPCR, and protein levels were assessed by immunohistochemistry. Transcriptomic and protein analysis of DI-Pso compared with that of healthy controls, plaque psoriasis, and AD skins revealed activation of T helper 17/IL-23 pathways associated with a significant expression of IL-36, surrogate marker of pustular psoriasis. By contrast, T helper 2 representative genes' expression was strongly decreased in DI-Pso across comparison. Matching analysis with public data of pustular psoriasis skin corroborated that DI-Pso and pustular psoriasis upstream regulators overlap, greater than the overlap with plaque psoriasis. Furthermore, DI-Pso showed strongly decreased expression of many barrier skin genes compared with healthy controls, plaque psoriasis, and AD. Our data indicate that the pathogenesis of DI-Pso relied on a shift of skin immune responses from a T helper 2 to an IL-36 and T helper 17 polarization and on intensified skin barrier alterations.
Collapse
Affiliation(s)
- Chloé Grolleau
- Dermatology Department, Saint Louis Hospital, Paris, France; Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| | - Andreea Calugareanu
- Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France; Dermatology Department, University Hospital of Lyon, Lyon, France
| | - Sarah Demouche
- Dermatology Department, Saint Louis Hospital, Paris, France; Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| | - Audrey Nosbaum
- Dermatology Department, University Hospital of Lyon, Lyon, France
| | - Delphine Staumont-Sallé
- Dermatology Department, U1286 Inserm Lille Inflammation Translational Research Institute, University of Lille, Lille, France
| | - Hélène Aubert
- Dermatology Department, University Hospital of Nantes, Nantes, France
| | - Charles Cassius
- Dermatology Department, Saint Louis Hospital, Paris, France; Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| | - Marie Jachiet
- Dermatology Department, Saint Louis Hospital, Paris, France
| | - Anne Saussine
- Dermatology Department, Saint Louis Hospital, Paris, France
| | - Martine Bagot
- Dermatology Department, Saint Louis Hospital, Paris, France
| | - Hervé Bachelez
- Dermatology Department, Saint Louis Hospital, Paris, France; Laboratory of Genetic of Skin Diseases, INSERM U1163, Imagine Institute, University of Paris, Paris, France
| | | | - Claire Hotz
- Dermatology Department, Henri Mondor Hospital, Créteil, France
| | - Aurélie Du Thanh
- Dermatology Department, University Hospital of Montpellier, Montpellier, France
| | - Marie-Noëlle Crépy
- Dermatology Department, Paris University Hospital of Cochin, Paris, France
| | - David Bergerat
- Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| | - Marine Merandet
- Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| | | | - Antonio Alberdi
- Technological Platerform of Saint- Louis Research Institute (IRSL), Saint-Louis Hospital, University of Paris, Paris, France
| | - Alexandre How-Kit
- Laboratory of Genomics, Foundation Jean Dausset (CEPH), Paris, France
| | - Jean-David Bouaziz
- Dermatology Department, Saint Louis Hospital, Paris, France; Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France.
| | - Hélène Le-Buanec
- Saint-Louis Research Institute, INSERM U976 - HIPI Unit, University of Paris, Paris, France
| |
Collapse
|
6
|
Grodner C, Bernigaud C, Lapadula S, Beringuer H, Billiet PA, Woerther PL, Billon R, Derhy H, Haye B, Hotz C, Pressiat C, Vodovar D, Rodriguez C, Fabresse N, de Prost N, Hua C, Chosidow O. Health products e-sale should be regulated: a case of necrotizing soft-tissue infection of the abdomen linked to self-injection of slimming products purchased on the internet. Int J Dermatol 2021; 61:e52-e54. [PMID: 34351634 DOI: 10.1111/ijd.15818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Revised: 06/15/2021] [Accepted: 07/08/2021] [Indexed: 10/20/2022]
Affiliation(s)
- Camille Grodner
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Charlotte Bernigaud
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Research Group Dynamyc, EA7380, Faculté de Santé de Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est Créteil, Créteil, France.,GrIDIST, Groupe Infectiologie Dermatologique - Infections Sexuellement Transmissibles, Société Française de Dermatologie, Paris, France
| | - Simone Lapadula
- Department of Maxillofacial and Plastic, Reconstructive, and Aesthetic Surgery, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Helene Beringuer
- Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France
| | | | - Paul-Louis Woerther
- Research Group Dynamyc, EA7380, Faculté de Santé de Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est Créteil, Créteil, France.,Microbiology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Raphaelle Billon
- Department of Maxillofacial and Plastic, Reconstructive, and Aesthetic Surgery, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Henri Derhy
- Department of Maxillofacial and Plastic, Reconstructive, and Aesthetic Surgery, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Benjamin Haye
- Department of Maxillofacial and Plastic, Reconstructive, and Aesthetic Surgery, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Claire Hotz
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Claire Pressiat
- Pharmacology-Toxicology Department, Pôle de Biologie, CHU Henri Mondor, Créteil, France
| | - Dominique Vodovar
- Centre AntiPoison de Paris - Fédération de toxicologie de l'APHP, Hôpital Fernand-Widal (APHP), Paris, France.,UFR de Médecine, Université de Paris, Paris, France.,UMRS 1144, INSERM, Paris, France
| | | | - Nicolas Fabresse
- Pharmacology-Toxicology Department, CH Raymond Poincaré, Garches, France
| | - Nicolas de Prost
- Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France
| | - Camille Hua
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,GrIDIST, Groupe Infectiologie Dermatologique - Infections Sexuellement Transmissibles, Société Française de Dermatologie, Paris, France
| | - Oliver Chosidow
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Research Group Dynamyc, EA7380, Faculté de Santé de Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est Créteil, Créteil, France.,GrIDIST, Groupe Infectiologie Dermatologique - Infections Sexuellement Transmissibles, Société Française de Dermatologie, Paris, France
| | | |
Collapse
|
7
|
Bergqvist C, Bernigaud C, Ingen-Housz-Oro S, Sujobert P, Hotz C, Lebre C, Ortonne N, Chosidow O. Intravenous immunoglobulins: an eye opener on the successful treatment of severe adult-onset paraprotein-associated xanthogranulomatosis. Clin Exp Dermatol 2021; 46:1346-1348. [PMID: 33969535 DOI: 10.1111/ced.14727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Accepted: 05/06/2021] [Indexed: 11/26/2022]
Affiliation(s)
- C Bergqvist
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.,Université Paris-Est Créteil, Créteil, France
| | - C Bernigaud
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.,Université Paris-Est Créteil, Créteil, France
| | - S Ingen-Housz-Oro
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France
| | - P Sujobert
- Department of Biological Haematology, Hôpital Lyon-sud, Pierre-Bénite, France
| | - C Hotz
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France
| | - C Lebre
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France
| | - N Ortonne
- Department of, Pathology, AP-HP, Henri Mondor Jospital, Créteil, France.,Université Paris-Est Créteil, Créteil, France
| | - O Chosidow
- Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.,Université Paris-Est Créteil, Créteil, France
| |
Collapse
|
8
|
Orvain C, Lin YL, Jean-Louis F, Hocini H, Hersant B, Bennasser Y, Ortonne N, Hotz C, Wolkenstein P, Boniotto M, Tisserand P, Lefebvre C, Lelièvre JD, Benkirane M, Pasero P, Lévy Y, Hüe S. Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa. J Clin Invest 2021; 130:3777-3790. [PMID: 32240121 DOI: 10.1172/jci131180] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Accepted: 03/31/2020] [Indexed: 12/28/2022] Open
Abstract
Hidradenitis suppurativa (HS) is a chronic, relapsing, inflammatory skin disease. HS appears to be a primary abnormality in the pilosebaceous-apocrine unit. In this work, we characterized hair follicle stem cells (HFSCs) isolated from HS patients and more precisely the outer root sheath cells (ORSCs). We showed that hair follicle cells from HS patients had an increased number of proliferating progenitor cells and lost quiescent stem cells. Remarkably, we also showed that the progression of replication forks was altered in ORSCs from hair follicles of HS patients, leading to activation of the ATR/CHK1 pathway. These alterations were associated with an increased number of micronuclei and with the presence of cytoplasmic ssDNA, leading to the activation of the IFI16/STING pathway and the production of type I IFNs. This mechanistic analysis of the etiology of HS in the HFSC compartment establishes a formal link between genetic predisposition and skin inflammation observed in HS.
Collapse
Affiliation(s)
- Cindy Orvain
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Yea-Lih Lin
- Equipe Labellisée Ligue contre le Cancer, Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier France
| | - Francette Jean-Louis
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Hakim Hocini
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Barbara Hersant
- Service de chirurgie plastique et reconstructive.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Yamina Bennasser
- Equipe Labellisée Ligue contre le Cancer, Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier France
| | - Nicolas Ortonne
- Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service d'anatomopathologie
| | - Claire Hotz
- Service de chirurgie plastique et reconstructive.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service de Dermatologie
| | - Pierre Wolkenstein
- Service de chirurgie plastique et reconstructive.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service de Dermatologie
| | - Michele Boniotto
- INSERM U955, Equipe 16, Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Pascaline Tisserand
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Cécile Lefebvre
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Jean-Daniel Lelièvre
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service d'Immunologie Clinique, and
| | - Monsef Benkirane
- Equipe Labellisée Ligue contre le Cancer, Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier France
| | - Philippe Pasero
- Equipe Labellisée Ligue contre le Cancer, Institut de Génétique Humaine, CNRS, Université de Montpellier, Montpellier France
| | - Yves Lévy
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service d'Immunologie Clinique, and
| | - Sophie Hüe
- INSERM U955, Equipe 16, Créteil, France.,Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France.,Groupe Hospitalier Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP), Créteil, France.,Faculté de Médecine, Université Paris-Est Créteil (UPEC), Créteil, France.,Service d'Immunologie Biologique, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France
| |
Collapse
|
9
|
Condamina M, Penso L, Tran VT, Hotz C, Guillem P, Villani AP, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H, Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts. Dermatology 2021; 237:748-758. [PMID: 33503635 DOI: 10.1159/000513447] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Accepted: 11/29/2020] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition substantially impacting patients' quality of life; the pathogenesis remains unclear, and treatment is complex and not yet standardized. Observational data are increasingly being used to evaluate therapeutics in "real-life" interventions, and the development of e-cohorts is offering new tools for epidemiological studies at the population level. OBJECTIVE The aim of this study was to describe the clinical characteristics and treatment history of HS participants in the Community of Patients for Research (ComPaRe) cohort and to compare these to other cohorts. METHODS We performed a cross-sectional study of the baseline data of HS participants in ComPaRe, an e-cohort of patients with chronic diseases. Data were collected using patient-reported questionnaires about clinical-dem-ographic aspects, quality of life, and treatment history. RESULTS A total of 396 participants (339 females, 57 males) were included (mean age 38 years); 83 (21%) had a family history of HS, 227 (57.3%) were current smokers, and 241 (60.9%) were overweight or obese. Most of the participants declared a Hurley stage II (n = 263, 66.4%) or III (n = 76, 20.3%). The breast was more frequently affected in women than men (37.5 vs. 5.3%, p < 0.0001), whereas the dorsal region was more frequently affected in men (39.5 vs. 10.9%, p < 0.0001). Increased disease stage was associated with obesity (25.9 vs. 33.8 vs. 51.3%, p = 0.02) and some HS localizations (genital [p < 0.005], pubis [p < 0.007], gluteal fold [p = 0.02], and groin [p < 0.0001]). The most frequently prescribed treatments were oral antibiotics (n = 362, 91.4%), especially amoxicillin-clavulanic acid and cyclins. Less than 10% of participants received biologics. Most of these results were consistent with previously published cohorts. CONCLUSION Recruitment of participants by such a web platform can be a faster way to get relevant scientific data for a wide variety of patients that could be used for epidemiological studies and to evaluate therapeutics in "real-life" interventions.
Collapse
Affiliation(s)
- Morgane Condamina
- Department of Dermatology-Venereology, Robert-Debré Hospital, Reims, France
| | - Laetitia Penso
- Paris-Est University, UPEC, EA 7379 EpiDermE (Epidemiologie En Dermatologie et Evaluation des Thérapeutiques), Créteil, France
| | - Viet-Thi Tran
- Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.,Centre de Recherche Épidémiologie et StatistiqueS (CRESS), Université de Paris, INSERM UMR1153, Paris, France
| | - Claire Hotz
- Department of Dermatology-Venereology, Henri Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France
| | - Philippe Guillem
- Department of Visceral and Digestive Surgery, Val d'Ouest Clinic, Écully, France.,RésoVerneuil, Paris, France.,European Hidradenitis Suppurativa Foundation, Dessau, Germany.,Groupe de Recherche en Proctologie de la Société Nationale Française de Coloproctologie, Paris, France
| | | | - Pierre Perrot
- Department of Plastic and Reconstructive Surgery, Hôtel-Dieu Hospital, Nantes, France
| | - Marie-France Bru
- Patient Member of the Scientific Committee of ComPaRe Verneuil Disease, Paris, France
| | - Eric Jacquet
- Department of Visceral Surgery, Beau Soleil Clinic, Montpellier, France
| | - Aude Nassif
- Medical Center, Institut Pasteur, Paris, France
| | - Hervé Bachelez
- Department of Dermatology-Venereology, Saint Louis Hospital (AP-HP), Sorbonne Paris Cité University Paris Diderot, Paris, France.,Laboratory of Genetics of Skin Diseases, INSERM U1163, Imagine Institute, Paris, France
| | - Pierre Wolkenstein
- Paris-Est University, UPEC, EA 7379 EpiDermE (Epidemiologie En Dermatologie et Evaluation des Thérapeutiques), Créteil, France.,Department of Dermatology-Venereology, Henri Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France
| | - Marie Beylot-Barry
- Department of Dermatology, INSERM 1053, CHU Bordeaux, Bordeaux University, Bordeaux, France
| | - Marie-Aleth Richard
- CEReSS-EA 3279, Research Center in Health Services and Quality of Life, Aix Marseille University, Dermatology Department, University Hospital La Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France
| | - Philippe Ravaud
- Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.,Centre de Recherche Épidémiologie et StatistiqueS (CRESS), Université de Paris, INSERM UMR1153, Paris, France
| | - Manuelle Viguier
- Department of Dermatology-Venereology, Robert-Debré Hospital, Reims, France
| | - Emilie Sbidian
- Paris-Est University, UPEC, EA 7379 EpiDermE (Epidemiologie En Dermatologie et Evaluation des Thérapeutiques), Créteil, France, .,Department of Dermatology-Venereology, Henri Mondor Hospital (AP-HP), Paris Est Créteil University, Créteil, France, .,INSERM, Centre d'Investigation Clinique 1430, Créteil, France,
| |
Collapse
|
10
|
Jannic A, Zehou O, Hotz C, Combemale P, Aerts I, Gene R, Ferkal S, Wolkenstein P. Deux ans de RCP nationale neurofibromatoses: émergence des anti-MEK. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Battesti G, Le Cleach L, Hotz C, Hüe S, Bonsang B, Gaudin O, Belmondo T, Chosidow O, Sbidian E, Wolkenstein P, Oro S. Évolution des caractéristiques cliniques et de la prise en charge des patients atteints de pemphigoïde bulleuse entre 2009 et 2020. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
12
|
Bergqvist C, Bernigaud C, Sujobert P, Oro S, Hotz C, Lebre C, Staumont-Salle D, Ortonne N, Chosidow O. Xanthogranulomatoses sévères associées à une gammapathie monoclonale difficiles à traiter : intérêt des IgIV. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Condamina M, Tran VT, Penso L, Hotz C, Guillem P, Villani A, Perrot P, Bru MF, Jacquet E, Nassif A, Bachelez H, Wolkenstein P, Beylot-Barry M, Richard MA, Ravaud P, Viguier M, Sbidian E. Caractéristiques cliniques des patients atteints d’hidradénite suppurée participants à la e-cohorte ComPaRe et comparaison avec les données de la littérature. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Battesti G, Belmondo T, Le Cleach L, Hotz C, Hüe S, Gaudin O, Bonsang B, Chosidow O, Sbidian E, Wolkenstein P, Oro S. Impact en vie réelle des tests immunologiques de la pemphigoïde bulleuse dans la décision d’arrêt du traitement et les rechutes. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Fertitta L, Hotz C, Sbidian E. Response to Marasca
et al
.’s letter about place of ultrasound in the evaluation of HS lesions. J Eur Acad Dermatol Venereol 2020; 34:e412-e413. [DOI: 10.1111/jdv.16359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 03/05/2020] [Indexed: 11/29/2022]
Affiliation(s)
- L. Fertitta
- Department of Dermatology Hôpital Henri Mondor Creteil France
| | - C. Hotz
- Department of Dermatology Hôpital Henri Mondor Creteil France
| | - E. Sbidian
- Department of Dermatology Hôpital Henri Mondor Creteil France
| |
Collapse
|
16
|
Fertitta L, Hotz C, Wolkenstein P, Méningaud JP, Sawan D, Hersant B, Sbidian E. Efficacy and satisfaction of surgical treatment for hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2019; 34:839-845. [PMID: 31799758 DOI: 10.1111/jdv.16135] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2019] [Accepted: 11/20/2019] [Indexed: 01/04/2023]
Abstract
BACKGROUND Surgery is a radical treatment for hidradenitis suppurativa (HS) and may be considered as the only one potentially curative. OBJECTIVES To characterize HS recurrence in patients after surgery and assess the risk factors of recurrence. METHODS We conducted a monocentric retrospective cohort study. All consecutive patients who had surgery (January 1, 2012 to March 31, 2017) were included. We estimated the rate of recurrence of HS lesions after surgery (<1 cm from the scar), and recurrence-associated factors were analysed by univariate then multivariate logistic regression, estimating odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS A total of 75 patients [median age 31.4 years (range 16-71); 36 females], corresponding to 115 interventions were included. The Hurley score at surgery was III for 70 (60%) patients. In total, 61/115 (53%) interventions involved wide excision and 50 (43%) limited local excision. The localizations were axillary folds (n = 46; 40%), buttocks (n = 15, 13%), genital area (n = 13; 11%), perineal area (n = 12; 10%) and inguinal folds (n = 18; 16%). We observed 11 (10%) complications and 40 (35%) recurrences. On multivariate analysis, probability of recurrence was associated with only one-stage surgical closure [OR 3.2 (95% CI 1.4-7.3), P = 0.005]. Overall, 44 (52%) patients were completely satisfied and 22 (26%) partially satisfied, and most (81%) considered the surgery the best treatment. CONCLUSIONS Hidradenitis suppurativa recurrence in our study was 35% and associated with one-stage surgical closures, but two-thirds of patients were satisfied with surgical treatment and would recommend surgery.
Collapse
Affiliation(s)
- L Fertitta
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - C Hotz
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - P Wolkenstein
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| | - J P Méningaud
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - D Sawan
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - B Hersant
- Department of Plastic Surgery, Hôpital Henri Mondor, Creteil, France
| | - E Sbidian
- Department of Dermatology, Hôpital Henri Mondor, Creteil, France
| |
Collapse
|
17
|
Orvain C, Lin YL, Jean-Louis F, Hocini H, Hersant B, Bennasser Y, Ortonne N, Hotz C, Wolkenstein P, Boniotto M, Tisserand P, Lefebvre C, Lelièvre JD, Benkirane M, Pasero P, Levy Y, Hüe S. Un stress réplicatif spontané des cellules souches du follicule pileux serait à l’origine de l’inflammation dans l’hidradénite suppurée. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Hotz C, Sbidian E, Ingen-Housz-Oro S, Chosidow O, Wolkenstein P. Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option. Acta Derm Venereol 2019; 99:1170-1171. [PMID: 31314122 DOI: 10.2340/00015555-3268] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Claire Hotz
- Department of Dermatology, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
| | | | | | | | | |
Collapse
|
19
|
Poizeau F, Sbidian E, Mircher C, Rebillat AS, Chosidow O, Wolkenstein P, Ravel A, Hotz C. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects. Acta Derm Venereol 2019; 99:351-352. [PMID: 30460373 DOI: 10.2340/00015555-3095] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Florence Poizeau
- Department of Dermatology, hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, 51 avenue du Maréchal de Lattre de Tassigny, FR-94000 Créteil, France.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Hirsch G, Drahy F, Bernigaud C, Hotz C, Hua C, Jannic A, Lu D, Oro S, Toukal F, Velter C, Zehou O, Wolkenstein P, Chosidow O, Duong TA. TELDERM Urgence : quels avis par téléexpertise ? Étude transversale mai 2016 et mai 2017. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.056] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
21
|
Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L. Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients—Exposed/Unexposed and Propensity Score-Matched Analyses. J Invest Dermatol 2018; 138:1293-1300. [DOI: 10.1016/j.jid.2017.12.034] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2017] [Revised: 11/26/2017] [Accepted: 12/20/2017] [Indexed: 11/27/2022]
|
22
|
Dumas M, Hua C, Hotz C, Velter C, Duong TA, Maraffi T, Ortonne N, Hüe S, Fardet L, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'. J Eur Acad Dermatol Venereol 2018. [PMID: 29524279 DOI: 10.1111/jdv.14935] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- M Dumas
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - C Hua
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - C Hotz
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - C Velter
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - T A Duong
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - T Maraffi
- Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France
| | - N Ortonne
- Pathology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Université Paris Est Créteil Val de marne, UPEC, Créteil, France
| | - S Hüe
- Université Paris Est Créteil Val de marne, UPEC, Créteil, France.,Immunology Department, AP-HP, Henri Mondor hospital, Créteil, France
| | - L Fardet
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - N de Prost
- Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France
| | - P Wolkenstein
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Université Paris Est Créteil Val de marne, UPEC, Créteil, France.,Referral Center for Severe Cutaneous Adverse Reactions, Créteil, France
| | - S Ingen-Housz-Oro
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Referral Center for Severe Cutaneous Adverse Reactions, Créteil, France
| | - O Chosidow
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Université Paris Est Créteil Val de marne, UPEC, Créteil, France.,Referral Center for Severe Cutaneous Adverse Reactions, Créteil, France
| |
Collapse
|
23
|
Velter C, Hotz C, Ingen-Housz-Oro S, Wolkenstein P, Fardet L. Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug. JAMA Dermatol 2018; 154:224-225. [PMID: 29261833 DOI: 10.1001/jamadermatol.2017.4607] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Affiliation(s)
- Charles Velter
- AP-HP, Hôpital Henri-Mondor, Department of Dermatology, Creteil, France.,Referral Center for Toxic Bullous Diseases, Île-de-France, France
| | - Claire Hotz
- AP-HP, Hôpital Henri-Mondor, Department of Dermatology, Creteil, France.,Referral Center for Toxic Bullous Diseases, Île-de-France, France
| | - S Ingen-Housz-Oro
- AP-HP, Hôpital Henri-Mondor, Department of Dermatology, Creteil, France.,Referral Center for Toxic Bullous Diseases, Île-de-France, France.,EA EpiDermE 7379, UPEC Université Paris Est-Créteil Val-de-Marne, France
| | - Pierre Wolkenstein
- AP-HP, Hôpital Henri-Mondor, Department of Dermatology, Creteil, France.,Referral Center for Toxic Bullous Diseases, Île-de-France, France.,EA EpiDermE 7379, UPEC Université Paris Est-Créteil Val-de-Marne, France
| | - Laurence Fardet
- AP-HP, Hôpital Henri-Mondor, Department of Dermatology, Creteil, France.,Referral Center for Toxic Bullous Diseases, Île-de-France, France.,EA EpiDermE 7379, UPEC Université Paris Est-Créteil Val-de-Marne, France
| |
Collapse
|
24
|
Poizeau F, Hotz C, Mircher C, Rebillat AS, Chosidow O, Ravel A, Wolkenstein P, Sbidian E. Prévalence et caractéristiques de l’hidradénite suppurée dans la trisomie 21 : une étude prospective sur 783 patients. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Fertitta L, Orvain C, Kervevan J, Hotz C, Jean-Louis F, Aguilar P, Hersant B, Bosc R, Wolkenstein P, Lelievre JD, Boniotto M, Hüe S. Hidradénite suppurée : infiltration de cellules dendritiques plasmacytoïdes dans les lésions. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Khoshim K, Hersant B, Hotz C, SidAhmed-Mezi M, Meningaud JP. Wound healing of cutaneous substance losses based on infectious, inflammatory and traumatic skin disorders: The experience of a center. ANN CHIR PLAST ESTH 2017; 63:330-337. [PMID: 29239728 DOI: 10.1016/j.anplas.2017.10.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 10/30/2017] [Indexed: 11/29/2022]
Abstract
INTRODUCTION There is no reference available concerning the standard healing time based on dermatological diseases responsible for cutaneous substance losses. The aim of our study was to assess the healing time after surgical debridement of necrotizing fasciitis (NF), hidradenitis suppurativa (HS) and skin necrosis due to trauma (SNT) based on multiples existing co-morbidities among these patients to provide surgeons with accurate scientific data in order to inform and educate patients and nurses who are practicing care under the supervision of the surgeon. MATERIALS AND METHODS This was a retrospective study. The primary endpoint was the time for complete wound healing, which was calculated from the time of the last surgical procedure to the complete wound healing corresponding to the time of complete reepithelialization, when daily dressings were no longer needed. RESULTS A total of 107 patients were included. The mean time for complete wound healing was 64.94±31.55 days in patients with NF, 45.70±21.40 days in patients with SNT and 75.02±26.41 days in patients with HS (SNT versus NF, P=0.004** and SNT versus HS, P<0.0001**). CONCLUSION The mean time for complete wound healing was 64.94 days in patients with NF, 45.70 days in patients with SNT, 75.02 days in patients with HS. This study can be considered as a referential based on the experience of a reference centre for these 3 pathologies (NF, HS, and SNT) whose aim is to inform plastic surgeons in order to anticipate the management or educate the patient.
Collapse
Affiliation(s)
- K Khoshim
- Département de chirurgie plastique et reconstructrice, hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - B Hersant
- Département de chirurgie plastique et reconstructrice, hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France.
| | - C Hotz
- Départementde dermatologie, hôpital Henri-Mondor, université Paris-Est, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - M SidAhmed-Mezi
- Département de chirurgie plastique et reconstructrice, hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| | - J P Meningaud
- Département de chirurgie plastique et reconstructrice, hôpital Henri-Mondor, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France
| |
Collapse
|
27
|
Tourte M, Hotz C, Béquignon E, Royer G, Allanore L, Oro S, Le Cleach L, Ortonne N, Wolkenstein P, Sbidian E, Chosidow O. Atteintes graves de l’érythème polymorphe : étude rétrospective sur 139 patients. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.212] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Gibson RS, Hotz C, Temple L, Yeudall F, Mtitimuni B, Ferguson E. Dietary Strategies to Combat Deficiencies of Iron, Zinc, and Vitamin A in Developing Countries: Development, Implementation, Monitoring, and Evaluation. Food Nutr Bull 2016. [DOI: 10.1177/156482650002100218] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In many developing countries, staple diets are plant-based and consumption of animal products is low. As a result, the intake and bioavailability of iron, zinc, and vitamin A are often poor. Deficiencies of these micronutrients can be prevented by using dietary diversification and modification, a strategy involving changes in food production practices, food selection patterns, and traditional household methods for preparing and processing indigenous foods. Strategies at the food production level include the use of fertilizers, plant breeding, and genetic engineering to enhance the content and bioavailability of micronutrients in plant-based staples and increase the yield of indigenous edible wild plants. Household strategies involve small-livestock production, aquaculture, gardening projects, and changes in certain food preparation and processing practices designed to alter the content of absorption modifiers in the diet, such as soaking, germination, fermentation, and enrichment. This review also describes how these household strategies can best be incorporated into existing food consumption patterns, and how their impact on the nutrient adequacy of the diets can be assessed. the steps necessary to test the acceptability of the modified recipes, to identify potential barriers to their adoption, and to implement them in the community are discussed, using an example from rural Malawi. Finally, methods of monitoring the progress and evaluating the impact of the dietary strategies in short- and long-term studies are included.
Collapse
Affiliation(s)
- R. S. Gibson
- Department of Human Nutrition, University of Otago, in Dunedin, New Zealand
| | - C. Hotz
- Department of Human Nutrition, University of Otago, in Dunedin, New Zealand
| | - L. Temple
- Department of Human Nutrition, University of Otago, in Dunedin, New Zealand
| | - F. Yeudall
- Department of Human Nutrition, University of Otago, in Dunedin, New Zealand
| | - B. Mtitimuni
- Bunda College of Agriculture, University of Malawi, Malawi
| | - E. Ferguson
- Department of Human Nutrition, University of Otago, in Dunedin, New Zealand
| |
Collapse
|
29
|
Ingen-Housz-Oro S, Ortonne N, Hotz C, Moroch J, Le Bras F, Chosidow O, Haioun C. Cutaneous Tumor of the Arm Revealing a Sporadic Burkitt Lymphoma. J Am Geriatr Soc 2016; 64:1141-2. [PMID: 27225370 DOI: 10.1111/jgs.14126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Saskia Ingen-Housz-Oro
- Department of Dermatology, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.,EA 7379 Epidémiologie en Dermatologie et Evaluation des Thérapeutiques, Université Paris-Est Créteil Val de Marne, Créteil, France
| | - Nicolas Ortonne
- Department of Pathology, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.,Université Paris-Est Créteil Val de Marne, Créteil, France
| | - Claire Hotz
- Department of Dermatology, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.,Université Paris-Est Créteil Val de Marne, Créteil, France
| | - Julien Moroch
- Department of Pathology, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France
| | - Fabien Le Bras
- Université Paris-Est Créteil Val de Marne, Créteil, France.,Lymphoid Malignancies Unit, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France
| | - Olivier Chosidow
- Department of Dermatology, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.,EA 7379 Epidémiologie en Dermatologie et Evaluation des Thérapeutiques, Université Paris-Est Créteil Val de Marne, Créteil, France.,Centre d'Investigation Clinique 1430, Assistance Publique - Hôpitaux de Paris, Créteil, France
| | - Corinne Haioun
- Université Paris-Est Créteil Val de Marne, Créteil, France.,Lymphoid Malignancies Unit, Assistance Publique - Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France
| |
Collapse
|
30
|
Hotz C, Boniotto M, Guguin A, Surenaud M, Jean-Louis F, Tisserand P, Ortonne N, Hersant B, Bosc R, Poli F, Bonnabau H, Thiébaut R, Godot V, Wolkenstein P, Hocini H, Lévy Y, Hüe S. Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. J Invest Dermatol 2016; 136:1768-1780. [PMID: 27206704 DOI: 10.1016/j.jid.2016.04.036] [Citation(s) in RCA: 104] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 03/17/2016] [Accepted: 04/08/2016] [Indexed: 01/06/2023]
Abstract
Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating, follicular disease of the skin. Despite a high prevalence in the general population, the physiopathology of HS remains poorly understood. The use of antibiotics and immunosuppressive agents for therapy suggests a deregulated immune response to microflora. Using cellular and gene expression analyses, we found an increased number of infiltrating CD4(+) T cells secreting IL-17 and IFN-γ in perilesional and lesional skin of patients with HS. By contrast, IL-22-secreting CD4(+) T cells are not enriched in HS lesions contrasting with increased number of those cells in the blood of patients with HS. We showed that keratinocytes isolated from hair follicles of patients with HS secreted significantly more IL-1β, IP-10, and chemokine (C-C motif) ligand 5 (RANTES) either constitutively or on pattern recognition receptor stimulations. In addition, they displayed a distinct pattern of antimicrobial peptide production. These findings point out a functional defect of keratinocytes in HS leading to a balance prone to inflammatory responses. This is likely to favor a permissive environment for bacterial infections and chronic inflammation characterizing clinical outcomes in patients with HS.
Collapse
Affiliation(s)
- Claire Hotz
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Michele Boniotto
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Aurélie Guguin
- Plateforme de Cytométrie en flux, IMRB, UFR de Médecine, Créteil, France
| | - Mathieu Surenaud
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Francette Jean-Louis
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Pascaline Tisserand
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Nicolas Ortonne
- Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Pathology Department, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France
| | - Barbara Hersant
- Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Plastic, Reconstructive and Aesthetic Surgery Department, Henri Mondor Hospital, Créteil, France
| | - Romain Bosc
- Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Plastic, Reconstructive and Aesthetic Surgery Department, Henri Mondor Hospital, Créteil, France
| | - Florence Poli
- Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Dermatology Department, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France
| | - Henri Bonnabau
- Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; INSERM U897, INRIA SISTM, Univ. Bordeaux Segalen ISPED, Bordeaux, France
| | - Rodolphe Thiébaut
- Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; INSERM U897, INRIA SISTM, Univ. Bordeaux Segalen ISPED, Bordeaux, France
| | - Véronique Godot
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Pierre Wolkenstein
- Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Dermatology Department, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France
| | - Hakim Hocini
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France
| | - Yves Lévy
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Service d'Immunologie Clinique, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.
| | - Sophie Hüe
- INSERM U955, Team 16, Créteil, France; Vaccine Research Institute (VRI), Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Université Paris Est Créteil, Faculté de Médecine, Créteil, France; Assistance publique, Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris Est Créteil, Val-de Marne (UPEC), Créteil, France; Service d'Immunologie Biologique, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France
| |
Collapse
|
31
|
Sbidian E, Hotz C, Seneschal J, Maruani A, Amelot F, Aubin F, Paul C, Beylot Barry M, Humbert P, Dupuy A, Caux F, Dupin N, Modiano P, Lepesant P, Ingen-Housz-Oro S, Mahé E, Bachelez H, Chosidow O, Wolkenstein P. Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013. Br J Dermatol 2015; 174:667-70. [PMID: 26406350 DOI: 10.1111/bjd.14199] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- E Sbidian
- AP-HP, Département de Dermatologie, UPEC, Hôpitaux Universitaires Henri Mondor, Créteil, F-94010, France. .,INSERM, Centre d'Investigation Clinique 1430, Créteil, F-94010, France. .,EA 7379 EpiDermE, UPEC, Université Paris-Est Créteil, Créteil, F-94010, France.
| | - C Hotz
- AP-HP, Département de Dermatologie, UPEC, Hôpitaux Universitaires Henri Mondor, Créteil, F-94010, France
| | - J Seneschal
- Département de Dermatologie, Centre de Référence des Maladies Cutanées Rares, INSERM U1035, Université de Bordeaux, Hôpital Saint-André, Bordeaux, F-33000, France
| | - A Maruani
- Service de Dermatologie, Hôpitaux Universitaires de Tours, Hôpital Trousseau, Université François Rabelais, Tours, F-37000, France
| | - F Amelot
- Département de Dermatologie, UMR CNRS 5165, INSERM 1056, Université Paul Sabatier, Hôpitaux Universitaires de Toulouse, Toulouse, F-31000, France
| | - F Aubin
- EA 3181, SFR4234, Département de Dermatologie, Centre Hospitalier Universitaire, Université de Franche Comté, Besançon, F-25000, France
| | - C Paul
- Département de Dermatologie, UMR CNRS 5165, INSERM 1056, Université Paul Sabatier, Hôpitaux Universitaires de Toulouse, Toulouse, F-31000, France
| | - M Beylot Barry
- Département de Dermatologie, Centre Hospitalier Universitaire, Hôpital du Haut Lévêque, Université de Bordeaux EA 2406, Pessac, F-33600, France
| | - P Humbert
- Département de Dermatologie, INSERM U1098, SFR4234, Centre Hospitalier Universitaire, Université de Franche Comté, Besançon, F-25000, France
| | - A Dupuy
- Département de Dermatologie, INSERM CIC 1414, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Université de Rennes 1, Rennes, F-35000, France
| | - F Caux
- AP-HP, Département de Dermatologie, Centre de Référence MAGEC, Université Paris 13, Hôpitaux Universitaires Avicenne, Bobigny, F-93000, France
| | - N Dupin
- AP-HP, Département de Dermatologie, Université Paris Descartes Paris V, Hôpitaux Universitaires Cochin, Paris, F-75014, France
| | - P Modiano
- GHICL, Département de Dermatologie, Hôpital Saint-Vincent-de-Paul, Lille, F-59000, France
| | - P Lepesant
- GHICL, Département de Dermatologie, Hôpital Saint-Vincent-de-Paul, Lille, F-59000, France
| | - S Ingen-Housz-Oro
- AP-HP, Département de Dermatologie, UPEC, Hôpitaux Universitaires Henri Mondor, Créteil, F-94010, France.,EA 7379 EpiDermE, UPEC, Université Paris-Est Créteil, Créteil, F-94010, France
| | - E Mahé
- Département de Dermatologie, Hôpital Victor Dupouy, Argenteuil, F-95100, France
| | - H Bachelez
- Sorbonne Paris Cité, Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Université Paris Diderot, Paris, F-75010, France
| | - O Chosidow
- AP-HP, Département de Dermatologie, UPEC, Hôpitaux Universitaires Henri Mondor, Créteil, F-94010, France.,INSERM, Centre d'Investigation Clinique 1430, Créteil, F-94010, France.,EA 7379 EpiDermE, UPEC, Université Paris-Est Créteil, Créteil, F-94010, France
| | - P Wolkenstein
- AP-HP, Département de Dermatologie, UPEC, Hôpitaux Universitaires Henri Mondor, Créteil, F-94010, France.,EA 7379 EpiDermE, UPEC, Université Paris-Est Créteil, Créteil, F-94010, France
| |
Collapse
|
32
|
Hotz C, Sbidian E, Chosidow O, Wolkenstein P. Hétérogénéité clinique dans l’hidradénite suppurée : étude des phénotypes selon le phototype. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
33
|
Hotz C, Sbidian E, Oro S, Chosidow O, Wolkenstein P. Thalidomide : une alternative thérapeutique dans l’hidradénite suppurée. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Hotz C, Ortonne N, Le Bras F, Moroch J, Chosidow O, Oro S, Haioun C. Tumeur cutanée rapidement évolutive du bras révélant un lymphome de Burkitt. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Daxhelet M, Suppa M, Benhadou F, Djamei V, Tzellos T, Ingvarsson G, Boer J, Martorell A, Ingram J, Desai N, Nassif A, Revuz J, Hotz C, Bettoli V, Deckers I, Jemec G, Prens E, Zouboulis C, del Marmol V. Establishment of a European Registry for hidradenitis suppurativa/acne inversa by using an open source software. J Eur Acad Dermatol Venereol 2015; 30:1424-6. [DOI: 10.1111/jdv.13267] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- M. Daxhelet
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium
| | - M. Suppa
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium
| | - F. Benhadou
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium
| | - V. Djamei
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; University Hospital of Zurich; Zurich Switzerland
| | - T. Tzellos
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; University Hospital of North Norway; Troms Norway
| | - G. Ingvarsson
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; University Hospital of North Norway; Troms Norway
| | - J. Boer
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Deventer Hospital; Deventer The Netherlands
| | - A. Martorell
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hospital of Manises; Valencia Spain
| | - J.R. Ingram
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology & Wound Healing; Cardiff University; Cardiff UK
| | - N. Desai
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- St John's Institute of Dermatology; London UK
| | - A. Nassif
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Pasteur Institute; Paris France
| | - J. Revuz
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Private practice; Paris France
| | - C. Hotz
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hospital Henri-Mondor; Créteil France
| | - V. Bettoli
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Azienda Ospedaliero-Universitaria di Ferrara; Ferrara Italy
| | - I.E. Deckers
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Erasmus University Medical Center; Rotterdam The Netherlands
| | - G.B. Jemec
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Health Sciences Faculty; Roskilde Hospital; University of Copenhagen; Copenhagen Denmark
| | - E. Prens
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Erasmus University Medical Center; Rotterdam The Netherlands
| | - C.C. Zouboulis
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Departments of Dermatology, Venereology, Allergology and Immunology; Dessau Medical Center; Dessau Germany
| | - V. del Marmol
- European Hidradenitis Suppurativa Foundation e.V.; Dessau Germany
- Department of Dermatology; Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium
| |
Collapse
|
36
|
Ingen-Housz-Oro S, Hotz C, Valeyrie-Allanore L, Sbidian E, Hemery F, Chosidow O, Wolkenstein P. Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre. Br J Dermatol 2015; 172:1455-7. [PMID: 25399843 DOI: 10.1111/bjd.13540] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- S Ingen-Housz-Oro
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Referral Center for Toxic and Autoimmune Disease, Créteil, France
| | - C Hotz
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France
| | - L Valeyrie-Allanore
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Referral Center for Toxic and Autoimmune Disease, Créteil, France
| | - E Sbidian
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Université Paris Est-Créteil Val de Marne, Créteil, France
| | - F Hemery
- Department of Medical Information, AP-HP, Henri Mondor Hospital, Créteil, France
| | - O Chosidow
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Referral Center for Toxic and Autoimmune Disease, Créteil, France.,Université Paris Est-Créteil Val de Marne, Créteil, France.,INSERM, Centre d'Investigation Clinique 006, AP-HP, Créteil, France
| | - P Wolkenstein
- Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.,Referral Center for Toxic and Autoimmune Disease, Créteil, France.,Université Paris Est-Créteil Val de Marne, Créteil, France.,INSERM, Centre d'Investigation Clinique 006, AP-HP, Créteil, France
| |
Collapse
|
37
|
Sbidian E, Hotz C, Taieb A, Maruani A, Amelot F, Aubin F, Paul C, Beylot-Barry M, Humert P, Dupuy A, Caux F, Dupin N, Modiano P, Lepesant P, Oro S, Mahé E, Bachelez H, Chosidow O, Wolkenstein P. Utilisation des anti-TNFα entre 2000 et 2013 chez les patients traités pour hidradénite suppurée : cohorte rétrospective française. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
38
|
Oro S, Hotz C, Valeyrie-Allanore L, Sbidian E, Hemery F, Chosidow O, Wolkenstein P. Pustulose exanthématique aiguë généralisée (PEAG) : évolution de la prise en charge entre 1994 et 2011. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Hotz C, Boniotto M, Guguin A, Surenaud M, Ortonne N, Bosc R, Chosidow O, Wolkenstein P, Lévy Y, Hüe S. Un défaut de peptides anti-microbiens à l’origine d’un cercle vicieux inflammatoire dans l’hidradénite suppurée. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Hotz C, Valeyrie-Allanore L, Haddad C, Bouvresse S, Ortonne N, Duong T, Ingen-Housz-Oro S, Roujeau J, Wolkenstein P, Chosidow O. Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol 2013; 169:1223-32. [DOI: 10.1111/bjd.12502] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/30/2013] [Indexed: 12/18/2022]
Affiliation(s)
- C. Hotz
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - L. Valeyrie-Allanore
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
- LIC EA 4393; Assistance Publique-Hôpitaux de Paris (APHP); Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - C. Haddad
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - S. Bouvresse
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - N. Ortonne
- Department of Pathology; Assistance Publique - Hôpitaux de Paris (APHP); Université - Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - T.A. Duong
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - S. Ingen-Housz-Oro
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - J.C. Roujeau
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - P. Wolkenstein
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
- LIC EA 4393; Assistance Publique-Hôpitaux de Paris (APHP); Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
| | - O. Chosidow
- Department of Dermatology; Referral Center for Toxic and Autoimmune Blistering Diseases; Université-Paris-Est Créteil Val de Marne (UPEC); Henri-Mondor Hospital; 51, avenue du Maréchal de Tassigny Créteil CEDEX 94010 France
- INSERM; Centre d'Investigation Clinique 006; APHP; Créteil F-94000 France
| |
Collapse
|
41
|
Hotz C, Valeyrie-Allanore L, Benjoar MD, Ortonne N, Vitte E, Bouvresse S, Brun-Buisson C, Wolkenstein P, Chosidow O. Clinical images: Necrosis at the tip of the nose in an 83-year-old man. ACTA ACUST UNITED AC 2011; 63:1762. [PMID: 21400482 DOI: 10.1002/art.30343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Claire Hotz
- Henri-Mondor Hospital, Assistance Publique Hôpitaux de Paris and UPEC Université Paris-Est Créteil, Créteil, France
| | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Gressier L, Hotz C, Lelièvre JD, Carlotti A, Buffet M, Wolkenstein P, Bagot M, Melica G, Ortonne N. Cutaneous Macroglobulinosis. ACTA ACUST UNITED AC 2010; 146:165-9. [DOI: 10.1001/archdermatol.2009.359] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
43
|
Farhi D, Hotz C, Poupet H, Gerhardt P, Morand P, Poyart C, Sednaoui P, Avril MF, Dupin N. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines. Acta Derm Venereol 2009; 89:484-7. [PMID: 19734973 DOI: 10.2340/00015555-0704] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Quinolone-resistant Neisseria gonorrhoeae rates have increased worldwide since 1994. The objective of this study was to appraise: (i) the antimicrobial susceptibility of Neisseria gonorrhoeae in a venereology clinic in Paris, between 2005 and 2007; and (ii) the factors associated with quinolone-resistant N. gonorrhoeae. A prospective study of consecutive cases was performed for the period 2005 to 2007. Susceptibility of N. gonorrhoeae to five antibiotics (ciprofloxacin, ceftriaxone, spectinomycin, penicillin G and tetracycline) was tested systematically. Clinical and epidemiological data were collected using a standardized form. Male-to-female sex ratio was 22.0. Median age was 30.0 years. Of 115 cases, 84 occurred in men having sex with men (72.6%) and 22 involved the anorectal area (19.1%). The rate of quinolone-resistant N. gonorrhoeae was 37.4% (43/115), without significant association with gender, age, sexual behaviour, past history of sexually transmitted diseases and susceptibility to other antibiotics. All N. gonorrhoeae were susceptible to ceftriaxone and spectinomycin. The rate of quinolone-resistant N. gonorrhoeae in Paris has been increasing since 2004. Ceftriaxone remains the gold standard treatment.
Collapse
Affiliation(s)
- David Farhi
- Department of Dermatology, UPRES1833 Centre National de Référence de la Syphilis, Paris, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Kishore R, Hotz C, Naseem HA, Brown WD. Transmission electron microscopy and X-Ray diffraction analysis of aluminum-induced crystallization of amorphous silicon in alpha-Si:H/Al and Al/alpha-Si:H structures. Microsc Microanal 2005; 11:133-137. [PMID: 15817142 DOI: 10.1017/s1431927605050208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2003] [Indexed: 05/24/2023]
Abstract
Solid phase crystallization of plasma-enhanced chemical-vapor-deposited (PECVD) amorphous silicon (alpha-Si:H) in alpha-Si:H/Al and Al/alpha-Si:H structures has been investigated using transmission electron microscopy (TEM) and X-ray diffraction (XRD). Radiative heating has been used to anneal films deposited on carbon-coated nickel (Ni) grids at temperatures between 200 and 400 degrees C for TEM studies. alpha-Si:H films were deposited on c-Si substrates using high vacuum (HV) PECVD for the XRD studies. TEM studies show that crystallization of alpha-Si:H occurs at 200 degrees C when Al film is deposited on top of the alpha-Si:H film. Similar behavior was observed in the XRD studies. In the case of alpha-Si:H deposited on top of Al films, the crystallization could not be observed at 400 degrees C by TEM and even up to 500 degrees C as seen by XRD.
Collapse
Affiliation(s)
- Ram Kishore
- Electron Microscopy, National Physical Laboratory, Dr. K.S. Krishnan Road, New Delhi 110012, India.
| | | | | | | |
Collapse
|
45
|
Hotz C, Gibson RS. Participatory nutrition education and adoption of new feeding practices are associated with improved adequacy of complementary diets among rural Malawian children: a pilot study. Eur J Clin Nutr 2004; 59:226-37. [PMID: 15483634 DOI: 10.1038/sj.ejcn.1602063] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To introduce practices for improving complementary feeding and evaluate their adoption and association with improved dietary intakes. DESIGN A quasiexperimental pilot study comparing dietary intakes from complementary foods among three intervention communities and one control community before and after the intervention, and adoption of new complementary feeding practices among intervention communities following the intervention. SETTING Rural subsistence communities in southern Malawi, Central Africa. SUBJECTS Mothers and their children aged 6 to 23 months receiving complementary foods. INTERVENTIONS A participatory, nutrition education intervention based on four locally adapted lessons for complementary feeding practices designed to increase: (i) total complementary food intake; (ii) energy and nutrient density of the complementary diet, and; (iii) iron and zinc bioavailability of the complementary diet. RESULTS Adoption rates for the four practices ranged from 25% for preparation of enriched porridges, to 10% for preparing soaked, pounded maize. The amount of complementary foods (g/day) and intakes of energy, animal protein, niacin, riboflavin, calcium, iron, and zinc, but not vitamin A, were significantly greater (P<0.05) in the intervention compared to control group, as were the energy, iron, and riboflavin density, and the estimated amount of bioavailable iron and zinc. CONCLUSIONS Several intervention practices were well accepted and adopted and were associated with improved adequacy of energy and nutrient intakes from the complementary diet. Such improvements were attributed mainly to greater total intakes and, to a lesser extent, enhanced dietary quality of the complementary foods.
Collapse
Affiliation(s)
- C Hotz
- Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
| | | |
Collapse
|
46
|
Temple L, Gibson R, Hotz C. Use of Soaking and Enrichment for Improving the Content and Bioavailability of Calcium, Iron, and Zinc in Complementary Foods and Diets of Rural Malawian Weanlings. J Food Sci 2002. [DOI: 10.1111/j.1365-2621.2002.tb08748.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
47
|
Hotz C, Gibson RS. Complementary feeding practices and dietary intakes from complementary foods amongst weanlings in rural Malawi. Eur J Clin Nutr 2001; 55:841-9. [PMID: 11593345 DOI: 10.1038/sj.ejcn.1601239] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/1999] [Revised: 01/09/2001] [Accepted: 03/17/2001] [Indexed: 11/09/2022]
Abstract
OBJECTIVE The objectives of this study were to estimate the quantity and nutritive quality of the complementary diet in rural Malawi, and to identify feeding practices, nutrients and dietary modifiers of iron and zinc bioavailability that may limit the quality of the diet. DESIGN This cross-sectional study design included an anthropometric survey, a feeding practices questionnaire, and an interactive, 24 h recall dietary data survey. SETTING Four rural villages in Balaka district, southern Malawi. SUBJECTS Mothers resident in the study communities with breastfed children aged up to 24 months were eligible. RESULTS Stunting was prevalent among these weanlings. Maize was the predominant food source, with limited contribution of animal foods. Deficits in dietary energy and several nutrients were found when compared to estimated needs. When expressed per kg body weight, energy intakes appeared adequate. The bioavailability of zinc was low due to a high phytate:zinc molar ratio. Iron bioavailability was also low due to low intake of absorption enhancers such as meat/fish/poultry protein and ascorbic acid. Dietary quality was poorest for 6 to 8-month-old infants. CONCLUSIONS Iron, zinc and calcium were the most limiting nutrients to the quality of the diet, partly exacerbated by the poor bioavailability of iron and zinc. Increased total intake and bioavailability of iron and zinc would improve the complementary diets. SPONSORSHIP This study was funded by the Thrasher Research Fund, Salt Lake City, Utah, USA.
Collapse
Affiliation(s)
- C Hotz
- Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
| | | |
Collapse
|
48
|
Gibson RS, Hotz C. Dietary diversification/modification strategies to enhance micronutrient content and bioavailability of diets in developing countries. Br J Nutr 2001; 85 Suppl 2:S159-66. [PMID: 11509105 DOI: 10.1079/bjn2001309] [Citation(s) in RCA: 111] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Both cereal staples and household diets can be manipulated to enhance the content of micronutrients and/or alter the levels of absorption modifiers to improve micronutrient bioavailability. Strategies described range from plant breeding, use of fertilizers and genetic engineering to changes in food preparation and processing methods at the household level involving soaking, fermentation and germination. The impact of five household strategies designed to enhance the content and bioavailability of iron, zinc and calcium in a representative daily menu for rural Malawian preschool children has been calculated using food composition data. In the five strategies, relishes based on small dried fish replaced plant-based relishes, maize-based porridges prepared with maize flour soaked to reduce its hexa (IP-6)- and penta (IP-5)-inositol phosphate content replaced conventional porridges; and a pumpkin-leaf relish replaced sweet potato to increase the retinol content of the daily menu. Comparison of the calculated energy, nutrient, and phytate content, and [phytate]:[zinc] molar ratios of the five modified menus compared with the unmodified menu emphasizes that to ensure that the estimated requirements for iron and zinc are met, the optimal strategy includes dried fish relish twice daily together with porridges prepared using soaked (or fermented) maize flour to reduce their hexa- and penta-inositol phosphate content. Implementation of these household strategies has the potential to increase the bioavailability of iron and zinc in rural Malawian diets from low to high.
Collapse
Affiliation(s)
- R S Gibson
- Department of Human Nutrition, University of Otago, Dunedin, New Zealand.
| | | |
Collapse
|
49
|
Abstract
Zinc supplementation trials assessing the response of growth and immunity have assisted in identifying populations at risk of zinc deficiency and the factors that contribute. A recent trial in Ethiopia demonstrated a high risk of zinc deficiency among young children, particularly among those who were stunted.
Collapse
Affiliation(s)
- C Hotz
- Program in International Nutrition, University of California, Davis 95616, USA
| | | |
Collapse
|
50
|
Hotz C, Gibson RS, Temple L. A home-based method to reduce phytate content and increase zinc bioavailability in maize-based complementary diets. Int J Food Sci Nutr 2001; 52:133-42. [PMID: 11303461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
This study aimed to develop and assess the feasibility of a home-based method to reduce the phytate content of maize and improve zinc bioavailability from maize-based complementary diets in rural Malawi. A method of extracting phytate through the soaking of pounded maize was developed, and found to reduce phytate content to 49% of unrefined maize. An educational program was used to teach the processing method to mothers of children receiving complementary foods in rural Malawian communities. Samples of maize flour prepared by this process by participants were collected and analysed for phytate and zinc content. Of these, 70% of samples were found to be adequately prepared; mean phytate content of these samples was 48% of unprocessed, unrefined maize flour controls. Most participants found the cooked product to have an acceptable taste (99%) and texture (68%), and felt the processing method took little or no extra time (86%) and was culturally acceptable (96%). The phytate and zinc content of the processed maize flour samples analysed from community prepared samples was substituted into the dietary analysis of complementary foods for 9- to 11-month-old children (n = 31). The bioavailability of zinc from the complementary diet would predict an increase from low (24%) to moderate (33%) levels.
Collapse
Affiliation(s)
- C Hotz
- Department of Human Nutrition, PO Box 56, University of Otago, Dunedin, New Zealand
| | | | | |
Collapse
|